Pijck J, Vuye A
Ann Biol Clin (Paris). 1983;41(6):383-92.
The authors present a detailed discussion on infectious agents and their development in the immediate future and the anti-microbial strategies which need to be developed. After describing a series of new diseases and the suspected microbial aetiology of little known syndromes, they describe the major lines of development of chemotherapy: new products which need to be developed; microbial enzyme inhibitors; selective transport. The proper use of the range of drugs already available should not be underestimated. Finally, the authors review recent developments and the prospects for the future in the immunological field: new vaccines or the improvement of existing vaccines and the immense possibilities of immunological techniques of identification.
作者们详细讨论了感染因子及其在不久的将来的发展情况,以及需要制定的抗菌策略。在描述了一系列新疾病和鲜为人知综合征的疑似微生物病因后,他们阐述了化疗的主要发展方向:需要研发的新产品;微生物酶抑制剂;选择性转运。不应低估现有各类药物的合理使用。最后,作者们回顾了免疫学领域的最新进展和未来前景:新疫苗或现有疫苗的改进,以及免疫鉴定技术的巨大可能性。